Bidirectional Relationship Between Kidney Disease Progression and Cardiovascular Events in Type 2 Diabetes
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Reframing Chronicity with Urgency in Chronic Kidney Disease ManagementClinical Journal of the American Society of Nephrology, 2024
- Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and AlbuminuriaCirculation, 2024
- Kidney and Heart Failure Events are Bidirectionally Associated in Patients with Type 2 Diabetes and Cardiovascular DiseaseESC Heart Failure, 2023
- Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart AssociationCirculation, 2023
- Longitudinal trajectories in renal function before and after heart failure hospitalization among patients with heart failure with preserved ejection fraction in the PARAGON‐HF trialEuropean Journal of Heart Failure, 2022
- Heart Failure in Patients with Diabetes and Chronic Kidney Disease: Challenges and OpportunitiesCardiorenal Medicine, 2021
- Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 DiabetesNew England Journal of Medicine, 2020
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and NephropathyNew England Journal of Medicine, 2019
- Canagliflozin and Cardiovascular and Renal Events in Type 2 DiabetesNew England Journal of Medicine, 2017